How to Invest in Psychedelics
Ryan Allway
April 29th, 2021
App, Exclusive, Psychedelics, Top Story
The psychedelics industry is following in the same projectile footsteps of the cannabis industry and could be on its way to becoming a multi-billion dollar industry. With the potential to transform mental health treatments. Researchers from Johns Hopkins and other leading institutions have embraced advancements in psychedelic research which has spawned a growing list of science-based biotech companies focused on further clinical development.
Let’s take a look at how investors can add exposure to the psychedelics sector and add into their portfolio without having to purchase multiple companies and actively manage their portfolio.
Invest in a Psychedelics ETF’s
Exchange-traded funds, or ETFs, are one of the easiest ways for investors to build exposure to different corners of the market into their portfolios. They provide instant diversification to a particular theme with exposure to many different stocks in a single security. At the same time, passive ETFs are typically less expensive to own than actively managed mutual funds.
The Horizons Psychedelic Stock Index ETF (NEO: PSYK) became the first exchange-traded fund in Canada to focus on psychedelics with its launch in January. With exposure to 23 publicly traded psychedelics companies, a single share of the ETF provides broad exposure to the entire psychedelics industry with a modest 0.85% expense ratio.
The ETF’s largest holdings include Seelos Therapeutics Inc. (NASDAQ: SEEL) at 16.56%, Mind Medicine Inc. (NASDAQ: MMED) at 8.86% and Compass Pathways plc (NASDAQ: CMPS) at 8.5%. Aside from the popular psychedelics pure plays, the fund holds large and diversified companies like Johnson & Johnson Inc. (NYSE: JNJ) and AbbVie Inc. (NYSE: ABBV).
Many of these companies have been strong performers in recent weeks and months. For example, MindMed shares have more than doubled from less than $3.00 in mid-April to around $6.00 in recent sessions.
The downside of ETFs is that they involve a management fee that cuts into long-term returns. In addition, the composition of most ETF portfolios is based on a passive indexing algorithm that may not reflect an ideal composition for an individual investor—it may be overweight or underweight in certain areas that an investor wants exposure.
Invest in Diversified Companies
Many companies provide ETF-like exposure to a market while adding a dose of active management. The most popular example is Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK.A), which owns everything from insurance companies to rail transportation companies. The advantage of these companies is the management team’s acumen.
Most psychedelic companies are focused on a particular area, such as specific clinical trials for anxiety, depression and PTSD, but some companies have embraced this kind of diversification.
For example, Delic Corp. (CSE: DELC) (OTC: DELCF) is building an ecosystem of media, mental health and science businesses focused on the nascent psychedelics industry and led by an all-star team.
Click Here: Download Delic’s Investor Presentation & Receive Updates
The company’s management team comes from the upper echelons of High Times, the iconic cannabis media brand, while its backers include names like Paul Rosen, who was a co-founder of PharmaCan Capital Corp. and served as its first President and CEO. With the right team in place, the company has begun to build its sprawling business.
After getting a start with a media presence, the company acquired Ketamine Infusion Centers, a business with 2 clinics and $1.5 million in revenue over the past three years. The company then acquired Complex Biotech Diversity Ventures (CBDV), a profitable business that provides both research services and a growing IP portfolio focusing on psilocybin and cannabis. Closing of the transactions are subject to customary conditions and are expected to close in the second quarter of 2021.
Looking Ahead
Investors have many different options when building exposure to psychedelics within their portfolio. Exchange-traded funds (ETFs) provide an easy way to access a wide array of exposure for your portfolio holdings of companies whereas companies like Delic Corp. (CSE: DELC) (OTC: DELCF) are focused on building their own diverse ecosystem under one roof with an exceptional management team.
For more information, visit the company’s website or download their investor presentation.
Disclaimer
The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Biome Grow (CSE: BIO) wholly owns Highland Grow, an Authorized Licensed Producer in Nova Scotia under the ACMPR, P-209 Inc., a company incorporated under the laws of the Province of Ontario and in the late stages of applying for a license under the ACMPR.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
